{
 "about": "One funder page of the Alleviate Index: a US foundation’s grants, as its own IRS returns show them.",
 "url": "https://sites.alleviate.org/index/funder/andy-derr-foundation-for-kidney-cancer-research-811302321",
 "source": {
  "name": "IRS returns",
  "form": "990",
  "periods": [
   "2025-12",
   "2024-12"
  ],
  "read": "2026-11-20"
 },
 "method": "https://sites.alleviate.org/index/method#funders",
 "funder": {
  "ein": "811302321",
  "name": "Andy Derr Foundation for Kidney Cancer Research",
  "kind": "grantmaking_public_charity",
  "form": "990",
  "city": "Fogelsville",
  "state": "PA",
  "country": "US",
  "latest_period": "2025-12",
  "assets_fmv_end": null,
  "giving": [
   {
    "period": "2025-12",
    "paid": 75000,
    "grants_listed": 2,
    "itemized": "itemized"
   },
   {
    "period": "2024-12",
    "paid": 55176,
    "grants_listed": 2,
    "itemized": "itemized"
   }
  ],
  "grants": {
   "latest_listed": 2,
   "median": 37500,
   "middle_half": [
    31250,
    43750
   ],
   "listed": 4,
   "linked": 0
  },
  "focus": [],
  "states": [
   {
    "grants": 4,
    "state": "PA"
   }
  ],
  "accepts_applications": null,
  "apply": null,
  "charity_profile": "https://sites.alleviate.org/index/org/andy-derr-foundation-for-kidney-cancer-research-811302321"
 },
 "recent_grants": [
  {
   "recipient": "LEHIGH VALLEY HEALTH NETWORK",
   "recipient_url": null,
   "city": "ALLENTOWN",
   "state": "PA",
   "country": "US",
   "period": "2025-12",
   "amount": 50000,
   "purpose": "FUNDING WAS PROVIDED TO THE LEHIGH VALLEY HEALTH NETWORK FOR A NUMBER OF ITS CANCER INSTITUTE'S 2025 AND 2026 INITIATIVES.",
   "form": "990"
  },
  {
   "recipient": "ST LUKES HOSPITAL",
   "recipient_url": null,
   "city": "BETHLEHEM",
   "state": "PA",
   "country": "US",
   "period": "2025-12",
   "amount": 25000,
   "purpose": "FUNDING TO ST LUKE'S UNIVERSITY HEALTH NETWORK WAS FOR THE SECOND YEAR OF THE TWO-YEAR IMMUNE GENE MUTATION RESEARCH PROJECT THAT EXPLORES HOW GENETIC MUTATIONS, SUCH AS BETA-2 MICROGLOBULIN (B2M), AFFECT PATIENT RESPONSE TO IMMUNOTHERAPY IN KIDNEY CANCER. IN ADDITION, THE FUNDS SPONSORED SLUHN'S CONFERENCE ATTENDANCE FOR RESEARCHERS.",
   "form": "990"
  },
  {
   "recipient": "LEHIGH VALLEY HEALTH NETWORK",
   "recipient_url": null,
   "city": "ALLENTOWN",
   "state": "PA",
   "country": "US",
   "period": "2024-12",
   "amount": 30176,
   "purpose": "FUNDING WAS PROVIDED TO THE LEHIGH VALLEY HEALTH NETWORK FOR A NUMBER OF ITS CANCER INSTITUTE'S 2024 AND 2025 INITIATIVES.",
   "form": "990"
  },
  {
   "recipient": "ST LUKES HOSPITAL",
   "recipient_url": null,
   "city": "BETHLEHEM",
   "state": "PA",
   "country": "US",
   "period": "2024-12",
   "amount": 25000,
   "purpose": "FUNDING TO ST LUKE'S UNIVERSITY HEALTH NETWORK WAS FOR A TWO-YEAR IMMUNE GENE MUTATION RESEARCH PROJECT THAT EXPLORES HOW GENETIC MUTATIONS, SUCH AS BETA-2 MICROGLOBULIN (B2M), AFFECT PATIENT RESPONSE TO IMMUNOTHERAPY IN KIDNEY CANCER. OUR SUPPORT NOT ONLY DRIVES CUTTING-EDGE RESEARCH AND DATA ANALYSIS BUT ALSO DEVELOPS FUTURE ONCOLOGY LEADERS THROUGH MENTORSHIP, CONFERENCE PARTICIPATION, AND PUBLICATION OPPORTUNITIES.",
   "form": "990"
  }
 ]
}
